Treatment-Related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer
American Journal of Clinical Oncology: Cancer Clinical Trials - United States
doi 10.1097/coc.0000000000000108
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)